Clinical Trials
3 trialsNCT00636545 2012-04-06
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors
Genta Incorporated
Phase 1 Completed
NCT00409383 2011-11-07
Abraxane and Temodar Plus Genasense in Advanced Melanoma
Genta Incorporated
Phase 1 Unknown
NCT00543231 2007-10-12
A Phase I Study of G3139 Subcutaneous in Solid Tumors
Genta Incorporated
Phase 1 Completed